PATENT CLAIM ANALYSIS

Application Number: 16078054
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "217100"]

Abstract:
Provided are a urea compound represented by general formula (I), a pharmaceutically acceptable salt thereof, a preparation method therefor, and use thereof as an FLT3 tyrosine protein kinase inhibitor, particularly in the prevention and/or treating of cancer.

Claim (Index 19):
A method for preparing a compound of general formula (I) or the pharmaceutically acceptable salt, solvate or prodrug thereof according to  claim 1 , comprising the following steps: the compound of formula (IV) is reacted with the compound of formula (V) in the present of a base in a suitable solvent at a suitable temperature and pH to give the compound of general formula (I); the solvent is preferably THF, acetonitrile, dichloromethane, or toluene, and the base is preferably triethylamine, N,N-diisopropylamine, DMAP, or pyridine; X, Y, A, A 1 , Z, W, R 1 , B, R, G, R 3  are as defined in  claim 1 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.15789
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14297790', '13389146', '10939324', '11201823', '12105408']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.786447231672233
- 35 USC 102 Novelty (BERT): 0.5261642990570085
- Combined Prediction Score: 0.7604189384107105
- Mean Citation Score: 335.0989120000001
- Max Citation Score: 349.75607
- Similarity Product: 255.0349567809189

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test